Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
CyBio AG / Contract / Ad hoc: CLS Laborautomationssysteme GmbH concludes Asset Deal with Manz Automation Tübingen GmbH Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
Jena, October 6 , 2008: The Executive Board of CyBio AG, Jena, (German Stock Exchange: General Standard, ISIN number: DE 0005412308) announces the formal closing of an asset deal agreement between CLS Laborautomationssysteme GmbH and Manz Automation Tübingen GmbH. CyBio AG owns 77,644 % of the share capital of the CLS Laborautomationssysteme GmbH.
After intensive negotiations the contract was signed last week. The parties agreed not to disclose the purchase price. Due to the sale of the assets of the CLS Laborautomationssysteme GmbH, the company will be dissolved with effect of September 30, 2008.
This terminates an activity for CyBio AG which was responsible for the biggest lost in the holding last year. In the future all automation activities will be handled in Jena at CyBio AG's automation group.
For further information please contact:
CyBio AG Anja Keiling Göschwitzer Str. 40 07745 Jena
WKN: 541230; ISIN: DE0005412308; Index: CDAX; Listed: General Standard in Frankfurter Wertpapierbörse, Geregelter Markt in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;
